Menu

Protara Therapeutics, Inc. TARA

Full chart Compare
Set alert

Price alert · TARA

All alert types
2.51 USD +0.21 (+9.13%)

At closeNov 9, 2026, 5:51 PM EST

2.51 0.00 0.00%

After hours · Nov 9, 5:51 PM ET

2.26 Day range 2.56
2.09 52-week range 7.82
YTD
-52.91%
1 year
-41.49%

Revenue & Expenses

Other Income → Expenses: $5.09MExpenses → Selling, General & Admin: $4.10MExpenses → Research & Development: $6.43MExpenses → Interest Expense: $857.00KGross Profit → Expenses: $2.95MRevenue → Gross Profit: $2.95MNet Loss → Expenses: $3.34MOther Income$5.09MGross Profit$2.95MNet Loss$3.34MExpenses$11.38MSelling, General & Admin$4.10MResearch & Development$6.43MInterest Expense$857.00KRevenue$2.95M

Latest period ending Dec 31, 2025 · select a line to chart its full history

TARA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-64.55M-49.15M-43.61M-67.06M-47.49M
-57.44M-44.60M-40.42M-65.95M-47.25M
-1.34-2.17-3.57-5.86-4.21
TARA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
49.66M162.80M39.59M24.13M35.72M
209.47M181.45M78.95M113.29M172.60M
13.06M14.32M10.63M11.21M10.68M
3.36M4.48M5.47M6.38M7.24M
196.41M167.13M68.32M102.08M161.91M
TARA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-56.37M-35.81M-37.56M-26.46M-34.50M
-139.49M19.16M53.11M14.95M-98.19M
82.72M139.87M-91.00K-90.00K-228.00K
-94.00K-63.00K-45.00K-120.00K-596.00K
-113.14M123.21M15.46M-11.60M-132.92M